login
login
Image header Agence Europe
Europe Daily Bulletin No. 7795
Contents Publication in full By article 35 / 39
ECONOMIC INTERPENETRATION / (eu) pharmaceuticals

The British group POWDERJECT PHARMACEUTICALS intends to acquire the vaccine activity of the biotechnology company CELLTECH for GBP 58 million. This activity recorded a loss of GBP 9.1 million in 1999.

Contents

THE DAY IN POLITICS
GENERAL NEWS
TIMETABLE
ECONOMIC INTERPENETRATION